Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study.

@article{Pilmore2011CardiovascularDM,
  title={Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study.},
  author={Helen Pilmore and Melissa A Skeans and J Jacob Snyder and Ajay K Israni and Bertram L. Kasiske},
  journal={Transplantation},
  year={2011},
  volume={91 5},
  pages={542-51}
}
BACKGROUND Cardiovascular disease (CVD) is the most common cause of death after kidney transplantation. Nevertheless, the use of potentially protective CVD medications has not been examined in a large international cohort of kidney transplant patients. METHODS Using the Patient Outcomes in Renal Transplantation database, we retrospectively examined CVD medication use in 14,236 kidney transplant patients from 10 centers worldwide at 4 and 12 months posttransplant. RESULTS Use of CVD… CONTINUE READING
14 Citations
20 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Similar Papers

Loading similar papers…